Elanco Animal Health Incorporated (ETR:5EA)
Germany · Delayed Price · Currency is EUR 20.06
0.00 (0.00%)
Inactive · Last trade price on Mar 16, 2026
Elanco Animal Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue | 5,020 | 4,715 | 4,439 | 4,417 | 4,411 | 4,764 |
Revenue Growth | 11.95% | 6.22% | 0.50% | 0.14% | -7.41% | 45.64% |
Cost of Revenue | 2,241 | 2,122 | 2,003 | 1,931 | 1,913 | 2,068 |
Gross Profit | 2,779 | 2,593 | 2,436 | 2,486 | 2,498 | 2,696 |
Selling, General & Admin | 1,512 | 1,423 | 1,308 | 1,280 | 1,259 | 1,395 |
Research & Development | 371 | 368 | 344 | 327 | 321 | 369 |
Amortization of Goodwill & Intangibles | 556 | 543 | 527 | 548 | 528 | 556 |
Operating Expenses | 2,439 | 2,334 | 2,179 | 2,155 | 2,108 | 2,320 |
Operating Income | 340 | 259 | 257 | 331 | 390 | 376 |
Interest Expense | -273 | -245 | -266 | -286 | -241 | -236 |
Interest & Investment Income | 45 | 45 | 31 | 9 | - | - |
Currency Exchange Gain (Loss) | -22 | -14 | -12 | -40 | -28 | -35 |
Other Non Operating Income (Expenses) | 16 | -12 | -4 | -40 | -10 | 22 |
EBT Excluding Unusual Items | 106 | 33 | 6 | -26 | 111 | 127 |
Merger & Restructuring Charges | -176 | -158 | -62 | -93 | -98 | -336 |
Impairment of Goodwill | - | - | - | -1,042 | - | - |
Gain (Loss) on Sale of Investments | - | - | -8 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | 640 | - | - | - |
Asset Writedown | -71 | -71 | -81 | -32 | -81 | - |
Legal Settlements | - | - | - | - | - | -10 |
Other Unusual Items | -25 | -28 | -7 | -2 | -4 | -352 |
Pretax Income | -166 | -224 | 488 | -1,195 | -72 | -571 |
Income Tax Expense | 33 | 8 | 150 | 36 | 6 | -88 |
Net Income | -199 | -232 | 338 | -1,231 | -78 | -483 |
Net Income to Common | -199 | -232 | 338 | -1,231 | -78 | -483 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 498 | 496 | 494 | 492 | 488 | 487 |
Shares Outstanding (Diluted) | 498 | 496 | 497 | 492 | 488 | 487 |
Shares Change | -0.50% | -0.18% | 1.02% | 0.82% | 0.23% | 10.38% |
EPS (Basic) | -0.40 | -0.47 | 0.68 | -2.50 | -0.16 | -0.99 |
EPS (Diluted) | -0.41 | -0.47 | 0.68 | -2.50 | -0.16 | -0.99 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 379 | 284 | 394 | 131 | 281 | 324 |
Free Cash Flow Per Share | 0.76 | 0.57 | 0.79 | 0.27 | 0.57 | 0.67 |
Gross Margin | 55.36% | 55.00% | 54.88% | 56.28% | 56.63% | 56.59% |
Operating Margin | 6.77% | 5.49% | 5.79% | 7.49% | 8.84% | 7.89% |
Profit Margin | -3.96% | -4.92% | 7.61% | -27.87% | -1.77% | -10.14% |
Free Cash Flow Margin | 7.55% | 6.02% | 8.88% | 2.97% | 6.37% | 6.80% |
EBITDA | 1,007 | 908 | 879 | 971 | 1,007 | 1,040 |
EBITDA Margin | 20.06% | 19.26% | 19.80% | 21.98% | 22.83% | 21.83% |
D&A For EBITDA | 667 | 649 | 622 | 640 | 617 | 664 |
EBIT | 340 | 259 | 257 | 331 | 390 | 376 |
EBIT Margin | 6.77% | 5.49% | 5.79% | 7.49% | 8.84% | 7.89% |
Effective Tax Rate | - | - | 30.74% | - | - | - |
Advertising Expenses | - | 314 | 236 | 207 | 201 | 248 |